Tourmaline Bio, Inc. (TRML)
(Delayed Data from NSDQ)
$26.30 USD
+0.78 (3.06%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $26.28 -0.02 (-0.08%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/12/2024
Time: -- |
9/2024 | $-0.84 | 0.00% |
Earnings Summary
For their last quarter, Tourmaline Bio, Inc. (TRML) reported earnings of -$0.68 per share, beating the Zacks Consensus Estimate of $-0.72 per share. This reflects a positive earnings surprise of 5.56%. Look out for TRML's next earnings release expected on November 12, 2024. For the next earning release, we expect the company to report earnings of -$0.84 per share, reflecting a year-over-year increase of 48.78%.
Earnings History
Price & Consensus
Zacks News for TRML
Here's What Could Help Tourmaline Bio, Inc. (TRML) Maintain Its Recent Price Strength
TRML: What are Zacks experts saying now?
Zacks Private Portfolio Services